JP2004528089A - メラニン細胞刺激ホルモン(msh)を含む生体適合材料および形成方法 - Google Patents
メラニン細胞刺激ホルモン(msh)を含む生体適合材料および形成方法 Download PDFInfo
- Publication number
- JP2004528089A JP2004528089A JP2002580977A JP2002580977A JP2004528089A JP 2004528089 A JP2004528089 A JP 2004528089A JP 2002580977 A JP2002580977 A JP 2002580977A JP 2002580977 A JP2002580977 A JP 2002580977A JP 2004528089 A JP2004528089 A JP 2004528089A
- Authority
- JP
- Japan
- Prior art keywords
- msh
- vehicle
- vehicle according
- receptor ligand
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Vascular Medicine (AREA)
- Botany (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0109348A GB0109348D0 (en) | 2001-04-17 | 2001-04-17 | Vehicle |
| GB0109347A GB0109347D0 (en) | 2001-04-17 | 2001-04-17 | Vehicle |
| PCT/GB2002/001713 WO2002083176A2 (en) | 2001-04-17 | 2002-04-17 | Biomaterials comprising a melanocyte stimulating hormone (msh), and method of forming |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004528089A true JP2004528089A (ja) | 2004-09-16 |
| JP2004528089A5 JP2004528089A5 (https=) | 2005-07-21 |
Family
ID=26245979
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002580977A Withdrawn JP2004528089A (ja) | 2001-04-17 | 2002-04-17 | メラニン細胞刺激ホルモン(msh)を含む生体適合材料および形成方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20040161443A1 (https=) |
| EP (1) | EP1381394A2 (https=) |
| JP (1) | JP2004528089A (https=) |
| CA (1) | CA2444518A1 (https=) |
| WO (1) | WO2002083176A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090232866A1 (en) * | 2003-10-07 | 2009-09-17 | Mariann Pavone-Gyongyosi | Oligopeptides as coating material for medical products |
| US7858108B2 (en) * | 2003-10-21 | 2010-12-28 | Richard Nagler | Elutable surface coating |
| JP2006068378A (ja) * | 2004-09-03 | 2006-03-16 | Terumo Corp | 血管内留置物 |
| GB2448153B (en) * | 2007-04-04 | 2011-12-28 | Camstent Ltd Mbe | Coated medical devices |
| GB2498356B (en) | 2012-01-11 | 2016-09-07 | Camstent Ltd | Calixarene-derived coatings for implantable medical devices |
| US20140088381A1 (en) * | 2012-09-26 | 2014-03-27 | Google Inc. | Facilitation of tear sample collection and testing using a contact lens |
| EP3865132B1 (en) * | 2017-04-28 | 2026-02-11 | The Schepens Eye Research Institute, Inc. | Methods and compositions for reducing corneal endothelial cell loss |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3502099A1 (de) * | 1985-01-23 | 1986-08-07 | Dieter Prof. Dr. Dr. 5883 Kierspe Aderhold | Therapeutisches, peptid- und/oder aminosaeurehaltiges mittel |
| FR2691465B1 (fr) * | 1992-05-25 | 1995-08-11 | Pf Medicament | Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant. |
| FR2735131B1 (fr) * | 1995-06-12 | 1997-08-22 | Rech De Pathologie Appliquee S | Conjugues d'msh avec un acide gras, leur procede de preparation et leur utilisation a titre de medicament |
| AU6242298A (en) * | 1997-01-17 | 1998-08-07 | Celadon Science, Llc | Methods for promoting healing of corneal resurfacing wounds |
| US20020037566A1 (en) * | 1997-04-16 | 2002-03-28 | Rees Riley S. | Cell-coated supports |
| AR012448A1 (es) * | 1997-04-18 | 2000-10-18 | Ipsen Pharma Biotech | Composicion en forma de microcapsulas o de implantes que comprende un excipiente biodegradable, polimero o co-polimero, o una mezcla de talesexcipientes, y una sustancia activa o una mezcla de sustancias activas, procedimiento para la preparacion de una sustancia soluble en agua de elevada |
| GB9914616D0 (en) * | 1999-06-23 | 1999-08-25 | Univ Sheffield | Attachment surface |
| WO2002006316A2 (en) * | 2000-07-14 | 2002-01-24 | Zycos, Inc. | Alpha-msh related compounds and methods of use |
-
2002
- 2002-04-17 EP EP02720208A patent/EP1381394A2/en not_active Withdrawn
- 2002-04-17 WO PCT/GB2002/001713 patent/WO2002083176A2/en not_active Ceased
- 2002-04-17 JP JP2002580977A patent/JP2004528089A/ja not_active Withdrawn
- 2002-04-17 US US10/474,994 patent/US20040161443A1/en not_active Abandoned
- 2002-04-17 CA CA002444518A patent/CA2444518A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002083176A3 (en) | 2003-08-14 |
| WO2002083176A8 (en) | 2002-11-28 |
| CA2444518A1 (en) | 2002-10-24 |
| EP1381394A2 (en) | 2004-01-21 |
| WO2002083176A2 (en) | 2002-10-24 |
| US20040161443A1 (en) | 2004-08-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shin et al. | Tissue-adhesive chondroitin sulfate hydrogel for cartilage reconstruction | |
| Dienes et al. | Semisynthetic hyaluronic acid-based hydrogel promotes recovery of the injured tibialis anterior skeletal muscle form and function | |
| CA2721507C (en) | Methods of generating and using procollagen | |
| JP4503825B2 (ja) | 生物学的組織において癒着の形成を防止するための方法および組成物 | |
| Bae et al. | Injectable biodegradable hydrogels: progress and challenges | |
| CN100506293C (zh) | 促进内皮细胞粘附的涂层 | |
| AU773914B2 (en) | Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups | |
| CA2239775C (en) | Crosslinked polymer compositions and methods for their use | |
| US5827735A (en) | Pluripotent mesenchymal stem cells and methods of use thereof | |
| AU2002315188B2 (en) | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use | |
| Yang et al. | Cell-mediated delivery of glucocorticoids from thiol-ene hydrogels | |
| WO2014104981A1 (en) | Self-assembled ultrashort peptides hydrogels for wound healing, skin care and cosmetics applications | |
| Lin et al. | Regulating MCP-1 diffusion in affinity hydrogels for enhancing immuno-isolation | |
| JP2009508991A (ja) | ポリマー組成物ならびにその作製方法および使用方法 | |
| CA2438193A1 (en) | Novel dendritic polymers and their biomedical uses | |
| US20050282747A1 (en) | Methods and compositions for wound healing | |
| Pinese et al. | Bioactive peptides grafted silicone dressings: A simple and specific method | |
| JP2011125351A (ja) | 細胞培養のための表面 | |
| JP2004528089A (ja) | メラニン細胞刺激ホルモン(msh)を含む生体適合材料および形成方法 | |
| Kader et al. | Plasmin-cleavable nanoparticles for on-demand release of morphogens in vascularized osteogenesis | |
| CN108472413A (zh) | 包含蛋白质-聚合物缀合物的无有机溶剂组合物及其用途 | |
| Trujillo et al. | Cytocompatibility evaluation of PEG-methylsulfone hydrogels | |
| WO2003030925A1 (fr) | Medicaments d'angiogenese | |
| WO2004100934A1 (fr) | Implant injectable de globine insoluble | |
| AU2002251276A1 (en) | Biomaterials comprising a melanocyte stimulating hormone (MSH), and method of forming |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Application deemed to be withdrawn because no request for examination was validly filed |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20050705 |